Hepatic steatosis secondary to capecitabine: a case report

INTRODUCTION: There are no known case reports of hepatic steatosis caused by oral fluoropyrimidines such as capecitabine. With increasing use of capecitabine since its approval for the treatment of metastatic colon cancer in 2001, and more recently for adjuvant treatment of colon cancer and treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Sheray N, Kim, Tae K, Siu, Lillian L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916012/
https://www.ncbi.nlm.nih.gov/pubmed/24576340
http://dx.doi.org/10.1186/1752-1947-4-227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916012/
https://www.ncbi.nlm.nih.gov/pubmed/24576340
http://dx.doi.org/10.1186/1752-1947-4-227

Ejemplares similares